Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

HIRA ALI

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1093155764
CMS profile
2790277
Location
SEWICKLEY, PA

General Payments · PY2019–2025

$727.49

  • Reported across 36 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$288.46

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $288.46 13

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $79.35 3
Medtronic, Inc. $58.69 3
Sequel Med Tech, LLC $26.98 1
SANOFI-AVENTIS U.S. LLC $25.00 1
DEXCOM, INC. $22.73 1
ABBVIE INC. $22.01 1
Abbott Laboratories $20.27 1
RECORDATI_RARE_DISEASES_INC. $19.35 1
Amphastar Pharmaceuticals, Inc. $14.08 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $19.50 1
PY2020 $51.27 3
PY2021 $86.67 5
PY2022 $19.51 1
PY2023 $42.75 2
PY2024 $219.33 11
PY2025 $288.46 13

Payment records · PY2025 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $20.27 05/06/2025 Food and Beverage Undisputed 06/30/2026 1240931057 CMS
ABBVIE INC. $22.01 10/23/2025 Food and Beverage Undisputed 06/30/2026 1201394876 CMS
Amphastar Pharmaceuticals, Inc. $14.08 12/10/2025 Food and Beverage Undisputed 06/30/2026 1223642840 CMS
Dexcom, Inc. $22.73 05/12/2025 Food and Beverage Undisputed 06/30/2026 1250489340 CMS
Medtronic, Inc. $21.71 01/15/2025 Food and Beverage Undisputed 06/30/2026 1219910923 CMS
Medtronic, Inc. $16.95 10/31/2025 Food and Beverage Undisputed 06/30/2026 1219910927 CMS
Medtronic, Inc. $20.03 12/04/2025 Food and Beverage Undisputed 06/30/2026 1219910925 CMS
Novo Nordisk Inc $28.35 04/22/2025 Food and Beverage Undisputed 06/30/2026 1188661267 CMS
Novo Nordisk Inc $16.18 09/24/2025 Food and Beverage Undisputed 06/30/2026 1188208385 CMS
Novo Nordisk Inc $34.82 11/05/2025 Food and Beverage Undisputed 06/30/2026 1188275481 CMS
RECORDATI_RARE_DISEASES_INC. $19.35 04/09/2025 Food and Beverage Undisputed 06/30/2026 1181711742 CMS
SANOFI-AVENTIS U.S. LLC $25.00 03/07/2025 Food and Beverage Undisputed 06/30/2026 1233575036 CMS
Sequel Med Tech, LLC $26.98 12/15/2025 Food and Beverage Undisputed 06/30/2026 1243729438 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.